Levomenol

Levomenol

SCHEMBL172398

CC(C)=CCCC(C)(O)C1CC=C(C)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 1.00
CYP3A4 P08684 2/20 1.00
STAT3 P40763 2/20 1.00
MEN1 O00255 1/20 1.00
MAPK1 P28482 1/20 1.00
KMT2A Q03164 1/20 1.00
CHRNA7 P36544 1/20 1.00
LMNA P02545 3/20 0.65
PTPN1 P18031 3/20 0.65
CES2 O00748 2/20 0.38
ESR1 P03372 2/20 0.33
HIF1A Q16665 1/20 0.33
EPAS1 Q99814 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Levomenol SCHEMBL12414344 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL24988 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL2728600 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL24989 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL31157846 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL14515491 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Bisabolol SCHEMBL13220166 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL1245143 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL4259122 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1
Levomenol SCHEMBL20838984 1.00 ALOX15 (1.00) ALOX15CYP3A4STAT3MEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4004 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240225970-A1 A METHOD OF REDUCING SKIN IRRITATION, COMPRISING THE APPLICATION TO THE SKIN OF AN ALPHA-BISABOLOL PREPARED BY A BIOTECHNOLOGICAL PROCESS GIVAUDAN SA (CH) 2024-07-11 US claimed
US-12029707-B2 Penetrating topical pain relief compositions and methods of use TECH SWERVE LLC (US) 2024-07-09 US claimed
US-11998522-B2 Penetrating topical pain relief compositions and methods of use TECH SWERVE LLC (US) 2024-06-04 US claimed
EP-4373507-A1 METHODS AND COMPOSITIONS FOR MICROENCAPSULATED COMPOUNDS Ojai Energetics PBC (US) 2024-05-29 EP claimed
EP-4356965-A2 CANNABINOID COMPOSITIONS AND METHODS OF PREPARATION THEREOF 5071, Inc. (US) 2024-04-24 EP claimed
US-20240108676-A1 ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS RIZUN NODARI (US) 2024-04-04 US claimed
EP-3651738-B1 CANNABINOID COMPOSITIONS AND METHODS OF PREPARATION THEREOF 5071 INC (US) 2024-04-03 EP claimed
US-11938208-B2 Antimicrobial mixture SYMRISE AG (DE) 2024-03-26 US claimed
US-20240066005-A1 FORMULATIONS FOR TREATING CLUSTER SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER ILERA THERAPEUTICS LLC 2024-02-29 US claimed
US-20240041935-A1 PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS CREATIVE MEDICAL TECHNOLOGIES, INC. (US) 2024-02-08 US claimed
WO-1995003779-A1 COSMETIC COMPOSITION CONTAINING HYDROXYACIDS UNILEVER PLC (GB) 1995-02-09 WO claimed
WO-1993025209-A1 COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF INFLAMMATIONS AND DERMATOSES INDUCED BY VIRUSES AND PROCESS FOR THE PREPARATION THEREOF FABULON RG KOZMETIKAI KFT. (HU) 1993-12-23 WO claimed
EP-0453920-B1 Method for the purification of alpha-bisabolol BASF AG (DE) 1993-12-08 EP claimed
CN-1076110-A Percutaneous is given so that the patch of skin-whitening materials PACIFIC CHEM CO LTD (KR) 1993-09-15 CN claimed
US-5132471-A Purification of α-bisabolol BASF AKTIENGESELLSCHAFT (DE) 1992-07-21 US claimed
EP-0453920-A1 Method for the purification of alpha-bisabolol BASF Aktiengesellschaft (DE) 1991-10-30 EP claimed
EP-0348560-A1 Oral composition LION CORPORATION (JP) 1990-01-03 EP claimed
EP-0253922-A1 Process for the purification of alpha-bisabolol Dragoco Gerberding & Co. GmbH (DE) 1988-01-27 EP claimed
CN-85108903-A Method for producing a novel anti-inflammatory agent 1986-06-10 CN claimed
US-3932533-A TREATMENT WITH BASE DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-01-13 US claimed